Julie R. Nangia

机构：Baylor College of Medicine, Children's Cancer Center, Dan L Duncan Comprehensive Cancer Center · ORCID：0000-0002-8326-2254

发表论文 185 篇 · 总被引 2255 次 · h-index 19

代表论文

• Abstract PS18-09: Endocrine Response in Women with Invasive Lobular Carcinoma (TBCRC 037): A Multicenter Randomized Clinical Trial (2025 · Clinical Cancer Research · 被引 2)
• Abstract P2-12-19: A Randomized Phase II Window-of-opportunity Trial of Ruxolitinib in Patients with High Risk and Premalignant Breast Conditions (2025 · Clinical Cancer Research · 被引 1)
• Multilevel barriers and supportive care preferences of metastatic breast cancer patients and their caregivers: a mixed-methods analysis (2025 · Supportive Care in Cancer · 被引 1)
• Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases (2026 · The Breast)
• Utilization of risk-reducing interventions among breast cancer patients with pathogenic germline variants across safety-net and academic hospitals. (2026 · Journal of Clinical Oncology)
• TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer (2026 · ESMO Open)